Serum Lipid Profile: Understanding Blood Fats
A serum lipid profile is a blood test that measures fat levels such as cholesterol and triglycerides. It is used to assess cardiovascular risk.
Things worth knowing about "Serum Lipid Profile"
A serum lipid profile is a blood test that measures fat levels such as cholesterol and triglycerides. It is used to assess cardiovascular risk.
What Is a Serum Lipid Profile?
A serum lipid profile (also known as a lipid panel or lipid screen) is a blood test that measures the levels of various fats (lipids) circulating in the blood. The results provide important information about a person´s risk of developing cardiovascular diseases such as heart attack or stroke. The test is performed on blood serum, which is the liquid component of blood after the blood cells have been removed.
What Values Are Measured?
A complete serum lipid profile typically includes the following parameters:
- Total cholesterol: The overall amount of all cholesterol fractions in the blood.
- LDL cholesterol (Low-Density Lipoprotein): Often referred to as bad cholesterol, it can contribute to the buildup of fatty deposits in artery walls.
- HDL cholesterol (High-Density Lipoprotein): Known as good cholesterol, it helps transport excess cholesterol away from the arteries.
- Triglycerides: Blood fats that serve as an energy source; elevated levels can increase the risk of heart disease.
- Non-HDL cholesterol: All cholesterol fractions except HDL, often used as a supplementary cardiovascular risk marker.
When Is a Serum Lipid Profile Ordered?
A serum lipid profile is recommended in a variety of situations:
- Routine health screenings, especially from the age of 35 onwards
- Suspected lipid metabolism disorders (dyslipidaemia or hyperlipidaemia)
- Known heart disease or diabetes mellitus
- Family history of heart attack or elevated blood lipid levels
- Monitoring during lipid-lowering therapy (e.g., with statins)
- Overweight or obesity
How Is the Test Performed?
For accurate results, patients are typically asked to fast for 9 to 12 hours before the test, meaning no food or sugary beverages during that period. A simple blood draw from a vein in the arm is sufficient. The sample is then analyzed in a laboratory.
Fasting vs. Non-Fasting Measurements
Current guidelines increasingly accept non-fasting measurements for an initial cardiovascular risk assessment, particularly for total cholesterol and HDL cholesterol. However, fasting measurements are still required when evaluating triglyceride levels in detail.
Reference Values and Interpretation
Reference ranges may vary slightly depending on the laboratory and individual risk factors. According to European guidelines, the following general target values apply:
- Total cholesterol: below 200 mg/dL (5.2 mmol/L) is desirable
- LDL cholesterol: below 100 mg/dL (2.6 mmol/L) for moderate-risk individuals; below 70 mg/dL (1.8 mmol/L) for high-risk patients
- HDL cholesterol: above 40 mg/dL (1.0 mmol/L) for men; above 50 mg/dL (1.3 mmol/L) for women
- Triglycerides: below 150 mg/dL (1.7 mmol/L)
Results must always be interpreted in the context of additional risk factors such as high blood pressure, smoking, diabetes, or a family history of cardiovascular disease.
Clinical Significance and Risk Assessment
Abnormal lipid levels, particularly elevated LDL cholesterol or reduced HDL cholesterol, are a major risk factor for the development of atherosclerosis (hardening and narrowing of the blood vessels). Atherosclerosis is one of the leading causes of heart attack and stroke. The serum lipid profile is therefore a central tool in cardiovascular risk stratification and preventive medicine.
Treatment of Abnormal Lipid Values
When lipid levels are elevated, the appropriate course of action depends on the extent of the abnormality and the individual risk profile:
- Dietary changes: Reducing saturated and trans fats while increasing fiber and unsaturated fatty acid intake
- Physical activity: Regular exercise can especially help raise HDL cholesterol levels
- Medication: Statins (e.g., atorvastatin, simvastatin), ezetimibe, PCSK9 inhibitors, or fibrates depending on the lipid pattern
- Treatment of underlying conditions: Such as diabetes or hypothyroidism, which can cause secondary lipid disorders
References
- Mach F et al. - 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 2020; 41(1): 111-188.
- World Health Organization (WHO) - Cardiovascular diseases (CVDs): Key facts. WHO, 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
- National Institutes of Health (NIH), National Heart, Lung, and Blood Institute - Blood Cholesterol: Diagnosis. Available at: https://www.nhlbi.nih.gov/health/blood-cholesterol/diagnosis
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCalorie expenditure
Calorie deficit
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Serum Lipid Profile-en